Delivery Order SPE2DB22D3301-SPE2DB24FZ0YU

Award Date 7/29/24
Potential Completion Date 7/30/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,072.54 firm-fixed-price delivery order is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,079.20 firm-fixed-price delivery order is for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML, a critical medical product, with a performance period through December 3, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.88 firm fixed-price delivery order is for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML medical products. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,291.22, is a delivery order for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML medical products. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $1,125.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIPRIVAN 200 MG/20 ML VIAL 20ML, a medical product, and has an ultimate completion date of March 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,075.38 firm fixed-price delivery order is for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML, a medical product, with a period of performance through March 4, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,449.44 firm fixed-price delivery order is for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML, a critical pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,173.47 for the product "DIPRIVAN 200 MG/20 ML VIAL 20ML". The award has an ultimate completion date of February 27, 2025 and is a Firm Fixed Price contract. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,683.26 firm fixed price contract is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a pharmaceutical product. The award has an ultimate completion date of July 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,735.53 firm fixed-price delivery order contract is for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML, a critical medical product. The award is not associated with a set-aside program and does not appear to have any major subcontractors. The contract is part of a larger $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ0YU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical care medication. The $6,771.10 firm-fixed-price delivery order has a completion date of July 30, 2024 and is not designated as a set-aside contract.

Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs, federal healthcare providers, and other government agencies and beneficiaries nationwide.

Generated 10/28/24, 9:44 AM